Transuretral electro-vaporisation combined with transurethral resection of the prostate in large prostates

Transurethral electro-vaporization of the prostate (TUEVP) is variant of transurethral resection (TURP), where roller is used to warm the prostate tissue to the point of evaporation. During the process, small blood vessels in the prostate are twisted and sealed. Therefore, during this procedure there is less bleeding during the procedure and postoperatively in relation to TURP. As a result, patients can leave the hospital at least 2 days after surgery, unlike the classic TURP where the hospital stay is 4 to 5 days. This procedure was conducted in 52 patients with benign prostatic hyperplasia (BPH) who had prostate size of 80-160 grams, avoiding postoperative transfusions, and shortening the hospital treatment up to two days. Before a discharge from the hospital, all but 2 patients (3.8%) had a spontaneous voiding, and irritant symptoms postoperatively occurred in 5 patients (9%) and disappeared after short-term treatment with the alpha blocker. This minimally invasive way is advantageous in terms of open access and TURP, especially in prostates larger than 80 grams, in order to avoid intraoperative and postoperative bleeding and shortened hospital stay. Key words: BPH, transurethral electrovaporization, TUR

Bladder mucinous adenocarcinoma as a diagnostic challenge: a case report

Primary bladder adenocarcinoma (PBA), especially the mucinous subtype, is a rare cancer that represents less than 2% of all bladder malignancies. Overlapping histopathological and immunohistochemical (IHC) features of PBA with metastatic colonic adenocarcinomas (MCA) make the final diagnosis very hard. We presented a 75-year-old woman presenting with hematuria and severe anemia in the last two weeks. The abdominal computed tomography scan showed a tumor-sized 2x2 cm right to the bladder dome. The patient underwent partial cystectomy without postoperative complication. The histopathologic and IHC showed mucinous adenocarcinoma and could not distinguish between the PBA from MCA. Investigations to exclude MCA revealed no other primary malignant site and suggested PBA. In conclusion, mucinous PBA requires ruling out any possibility of a metastatic lesion that could arise from other organs. Treatment should be considered an individual approach based on the tumor location and size, the patient´s age, general condition, and comorbidities